Sequenom Posts 27 Percent Increase in Q1 Revenues, Cuts Loss | GenomeWeb

By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – Sequenom reported after the close of the market Thursday that its first-quarter revenues increased 27 percent while it cut its net loss around 25 percent year over year.

The San Diego-based molecular diagnostics and research instruments firm reported total revenues of $13.5 million for the three months ended March 31, compared to $10.6 million for the first quarter of 2010. It beat analysts' consensus estimate for revenues of $12.7 million.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Nature this week: genetic link between birth weight and adult-onset diseases, and more.

Even with all the current enthusiasm for gene therapies, Tech Review cautions that they are mostly in the early stages of development.

DNA phenotyping puts a potential face to a suspect in a nearly 25-year-old murder, the AP reports.

Researchers discuss the need for antibody standards at a meeting, NPR reports.